Texan Capital Management - Q4 2016 holdings

$214 Million is the total value of Texan Capital Management's 147 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .

 Value Shares↓ Weighting
NewMedtronic PLC$1,285,00018,038
+100.0%
0.60%
ABMD NewAbiomed Inc$982,0008,719
+100.0%
0.46%
SLCA NewU.S. Silica Holdings Inc$668,00011,785
+100.0%
0.31%
ABBV NewAbbVie Inc$512,0008,171
+100.0%
0.24%
FMSA NewFairmount Santrol Holdings Inc$508,00043,065
+100.0%
0.24%
PFE NewPfizer Inc$424,00013,041
+100.0%
0.20%
ABT NewAbbott Laboratories$218,0005,671
+100.0%
0.10%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Dril-Quip Inc.19Q4 201719.6%
Main Street Capital Corp19Q4 20174.1%
Enterprise Prods Partners LP19Q4 20173.4%
Exxon Mobil Corp19Q4 20172.8%
Magellan Midstream Partners LP19Q4 20173.1%
General Electric Co19Q4 20172.4%
EOG Resources19Q4 20172.5%
Bristol Myers Squibb Co19Q4 20173.1%
Plains All Amern Pipeline19Q4 20171.9%
Kinder Morgan Inc Del19Q4 20174.1%

View Texan Capital Management's complete holdings history.

Latest filings
TypeFiled
13F-HR2018-02-02
13F-HR2017-10-26
13F-HR2017-07-13
13F-HR2017-05-15
13F-HR2017-02-03
13F-HR2016-11-02
13F-HR2016-08-03
13F-HR2016-05-11
13F-HR2016-01-27
13F-HR2015-11-10

View Texan Capital Management's complete filings history.

Compare quarters

Export Texan Capital Management's holdings